FDA Reportedly Reviewing Eli Lilly Prozac PapersDec 31, 2004 | CBS MarketWatch The U.S. Food and Drug Administration is reviewing internal Eli Lilly documents that suggest the antidepressant Prozac may be linked to violent behavior, the Wall Street Journal reported Friday, quoting a U.K. medical journal.
The documents, which were part of a 1994 civil suit against Prozac maker Eli Lilly (LLY), had disappeared, the British Medical Journal reported. The BMJ recently received the papers through an anonymous sender and turned them over to the FDA, according to the Jan. 1 issue of the publication.
A spokeswoman for the FDA declined to comment, the Wall Street Journal reported. An Eli Lilly communications manager said the company couldn't comment because it hadn't seen copies of the documents cited by the report, the Journal said.
The Wall Street Journal said that the British Medical Journal reported the documents appear to suggest a link between Prozac and suicide attempts and violence.
The documents were being used in the case of Joseph Wesbecker, who in 1989, while being treated with Prozac, went on a shooting spree, killing eight people before killing himself.
The FDA recently warned that Prozac and similar antidepressants could cause "activation" stimulating agitation, panic attacks and aggression.